Serological biomarkers such as carcinoembryonic antigen (CEA) and cytokeratin 19 soluble fragment (CYFRA21-1) are tumor associated antigens (TAAs) commonly used for NSCLC, but their utilities in early stage tumors and prognosis of surgical outcome are limited (27). The gene discussed is CEACAM5; the disease is neoplasm.